Leo Groenewegen
Chief Executive Officer at NBAB, Nordic BioAnalysis AB
Profile
Leo Groenewegen is currently the Chief Executive Officer at NBAB, Nordic BioAnalysis AB.
Prior to this, he worked as the Chief Financial Officer at NextCell Pharma AB.
Leo Groenewegen active positions
| Companies | Position | Start |
|---|---|---|
NBAB, Nordic BioAnalysis AB
 NBAB, Nordic BioAnalysis AB BiotechnologyHealth Technology Part of Ilya Pharma AB, NBAB, Nordic BioAnalysis AB engages in bio analytical development, validation and analysis of medicines. The company is based in Södertälje, Sweden. The Swedish company was founded in 2010. The CEO is Leo Groenewegen. NBAB was acquired by Ilya Pharma AB on April 19, 2022. | Chief Executive Officer | 2022-08-31 |
Former positions of Leo Groenewegen
| Companies | Position | End |
|---|---|---|
| NEXTCELL PHARMA AB | Director of Finance/CFO | - |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| NEXTCELL PHARMA AB | Health Technology |
| Private companies | 1 |
|---|---|
NBAB, Nordic BioAnalysis AB
NBAB, Nordic BioAnalysis AB BiotechnologyHealth Technology Part of Ilya Pharma AB, NBAB, Nordic BioAnalysis AB engages in bio analytical development, validation and analysis of medicines. The company is based in Södertälje, Sweden. The Swedish company was founded in 2010. The CEO is Leo Groenewegen. NBAB was acquired by Ilya Pharma AB on April 19, 2022. | Health Technology |
- Stock Market
- Insiders
- Leo Groenewegen
